AbbVie, Lilly Face New Delays in FDA Approval for Expanded Use of Janus Kinase Inhibitors
Guselkumab Promising for Psoriatic Arthritis with Axial Symptoms
Health Canada Approves Upadacitinib to Treat Adults with PsA
Add-On Voclosporin Improves Outcomes in Lupus Nephritis
Myositis Management: Clinical Trials Provide New Insights into Treatment Options
Upadacitnib for RA: Researchers Compared Upadacitinib with Placebo & Adalimumab in Patients with RA & an Inadequate Response to Methotrexate
Immunosuppressive Medicines Do Not Worsen COVID-19 Outcomes
Research Outlines Benefits of bDMARDs to Treat Early RA
Study Examines Tofacitinib’s Long-Term Cardiovascular Risk & More
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 23
- Next Page »